Aorto Medical
Aorto Medical has developed a cutting-edge Flow Modulation Stent (FMS) technology that leverages percutaneous treatment methods for congestive heart failure. This innovative therapy is designed to be minimally invasive, safe, and highly effective. Patients can expect a speedy recovery time, which has the potential to significantly decrease the number of preventable rehospitalizations. Ultimately, with its FMS technology, Aorto Medical aims to improve patient outcomes and set a new standard of care in cardiac treatments.
Key people 🧑🤝🧑
- Dr. Youssef El Azouzi - Founder & CEO
- Saleem Abdulganiy - Co-founder & CTO
- Sulaiman Hussaini - COO
- Yehia Ghanem - Co-founder & PMO
Highlights ⭐
Content in this section is available for DHArab Premium Members only. We manually enter this information so you can save time researching different companies.
Existing users 👉 click here to login
Looking to become a member? 👉 click here for more information
Awards & Recognitions 🏆
- 2024 GITEX Africa: One of the leading startups
- 2019 Stars of Science
